118. 脊髄髄膜瘤 Myelomeningocele Clinical trials / Disease details


臨床試験数 : 10 薬物数 : 18 - (DrugBank : 7) / 標的遺伝子数 : 8 - 標的パスウェイ数 : 12

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04468568
(ClinicalTrials.gov)
January 8, 20171/3/2020In Utero Repair of Myelomeningocele: Atosiban Versus TerbutalineAssessment of Maternal Blood Gas Changes When Using Atosiban and Terbutaline as Tocolytic Agents, During in Utero Repair of MyelomeningoceleMyelomeningocele;Terbutaline Adverse Reaction;Pregnancy; Malformation Central Nervous SystemDrug: Atosiban;Drug: TerbutalineUniversity of Sao Paulo General HospitalNULLRecruiting18 Years40 YearsFemale28N/ABrazil